{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:04:18Z","timestamp":1790719458563,"version":"4.1.0"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373478"],"award-info":[{"award-number":["81373478"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302835"],"award-info":[{"award-number":["81302835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370750"],"award-info":[{"award-number":["81370750"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Andrologia"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1111\/and.13021","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T13:12:38Z","timestamp":1525266758000},"page":"e13021","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacodynamic and pharmacokinetic studies and prostatic tissue distribution of fosfomycin tromethamine in bacterial prostatitis or normal rats"],"prefix":"10.1155","volume":"50","author":[{"given":"L.","family":"Fan","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences; Nanjing Tech University; Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Shang","sequence":"additional","affiliation":[{"name":"Deparment of Andrology; Jinling Hospital; Nanjing University School of Medicine\/Nanjing General Hospital of Nanjing Military Region; Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences; Nanjing Tech University; Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences; Nanjing Tech University; Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5292-9087","authenticated-orcid":false,"given":"Q.","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences; Nanjing Tech University; Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"10.1111\/and.13021-BIB0001|and13021-cit-0001","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00192-006-0190-y","article-title":"Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy?","volume":"18","author":"Bayrak","year":"2007","journal-title":"International Urogynecology Journal"},{"key":"10.1111\/and.13021-BIB0002|and13021-cit-0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000074526","article-title":"Penetration of antimicrobial agents into the prostate","volume":"49","author":"Charalabopoulos","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1111\/and.13021-BIB0003|and13021-cit-0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-8-12","article-title":"Acute bacterial prostatitis: Heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis","volume":"8","author":"Etienne","year":"2008","journal-title":"BMC Infectious Diseases"},{"key":"10.1111\/and.13021-BIB0004|and13021-cit-0004","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/BF01708240","article-title":"Susceptibility testing quality control studies with fosfomycin tromethamine","volume":"16","author":"Fuchs","year":"1997","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"10.1111\/and.13021-BIB0005|and13021-cit-0005","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/cid\/cit704","article-title":"Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?","volume":"58","author":"Gardiner","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/and.13021-BIB0006|and13021-cit-0006","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cmi.2015.05.022","article-title":"Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin","volume":"21","author":"Giske","year":"2015","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1111\/and.13021-BIB0007|and13021-cit-0007","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/cid\/civ436","article-title":"Fosfomycin for treatment of prostatitis: New tricks for old dogs","volume":"61","author":"Grayson","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/and.13021-BIB0008|and13021-cit-0008","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2169\/internalmedicine.53.3098","article-title":"Fosfomycin for the treatment of prostate infection","volume":"53","author":"Hagiya","year":"2014","journal-title":"Internal Medicine"},{"key":"10.1111\/and.13021-BIB0009|and13021-cit-0009","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"10.1111\/and.13021-BIB0010|and13021-cit-0010","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.02611-15","article-title":"Long-term fosfomycin-tromethamine oral therapy for difficult-to-treat chronic bacterial prostatitis","volume":"60","author":"Los-Arcos","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1111\/and.13021-BIB0011|and13021-cit-0011","first-page":"71","article-title":"Conventional bacteriology in prostatitis patients: Microbiological bias, problems and epidemiology on 1686 microbial isolates","volume":"79","author":"Mazzoli","year":"2007","journal-title":"Archivio italiano di urologia, andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica"},{"key":"10.1111\/and.13021-BIB0012|and13021-cit-0012","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"issue":"Suppl 1","key":"10.1111\/and.13021-BIB0013|and13021-cit-0013","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijantimicag.2006.05.009","article-title":"Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae","volume":"28","author":"Muratani","year":"2006","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1111\/and.13021-BIB0014|and13021-cit-0014","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/AAC.36.1.198","article-title":"Susceptibilities of anaerobic bacteria isolated from animals with ovine foot rot to 28 antimicrobial agents","volume":"36","author":"Piriz","year":"1992","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1111\/and.13021-BIB0015|and13021-cit-0015","first-page":"e004157","article-title":"Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: An uncontrolled, open-label, multicentre study","volume":"3","author":"Qiao","year":"2013","journal-title":"British Medical Journal Open"},{"key":"10.1111\/and.13021-BIB0016|and13021-cit-0016","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2009.08.001","article-title":"The clinical consequences of antimicrobial resistance","volume":"12","author":"Rice","year":"2009","journal-title":"Current Opinion in Microbiology"},{"key":"10.1111\/and.13021-BIB0017|and13021-cit-0017","first-page":"420","article-title":"Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study","volume":"55","author":"Rudenko","year":"2005","journal-title":"Arzneimittel-Forschung"},{"key":"10.1111\/and.13021-BIB0018|and13021-cit-0018","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0924-8579(03)00231-0","article-title":"Why fosfomycin trometamol as first line therapy for uncomplicated UTI?","volume":"22","author":"Schito","year":"2003","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1111\/and.13021-BIB0019|and13021-cit-0019","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.12659\/MSM.890902","article-title":"Opening tight junctions may be key to opening the blood-prostate barrier","volume":"20","author":"Shang","year":"2014","journal-title":"Medical Science Monitor"},{"key":"10.1111\/and.13021-BIB0020|and13021-cit-0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1345\/aph.17227","article-title":"Single-dose treatment of acute cystitis with fosfomycin tromethamine","volume":"32","author":"Stein","year":"1998","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1111\/and.13021-BIB0022|and13021-cit-0022","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/jac\/dkv221","article-title":"In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa","volume":"70","author":"Walsh","year":"2015","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1111\/and.13021-BIB0024|and13021-cit-0024","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ja.2014.5","article-title":"In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"67","author":"Xu-hong","year":"2014","journal-title":"The Journal of Antibiotics"}],"container-title":["Andrologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fand.13021","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/and.13021\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:37:14Z","timestamp":1671539834000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/and.13021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1111\/and.13021","archive":["Portico"],"relation":{},"ISSN":["0303-4569"],"issn-type":[{"value":"0303-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,2]]}}}